NAME

Question types


Start with


Question limit

of 60 available terms

Advertisement Upgrade to remove ads
Print test

5 Written questions

5 Matching questions

  1. 2406.01
  2. 2402
  3. 2406.02
  4. 2421.01
  5. 2421.04
  1. a Description in Application Specification
    37 CFR 1.804(a)
    requirement for a specific identification consistent with the description requirement of the first paragraph of 35 U.S.C. 112 and provides an antecedent basis for the biological material which either has been or will be deposited before the patent is granted.
  2. b Deposit After Filing Date-Corroboration

    When the original deposit is made after the effective filing date of an application for patent, an applicant is required to promptly submit a statement from a person in a position to corroborate that the biological material which is deposited is a biological material specifically identified in the application (the filing date of which is relied upon) as filed. - See more at: http://www.wikilawschool.net/wiki/MPEP_2400#sthash.r1onQWb8.dpuf
  3. c Future Changes to the Sequence Rules
  4. d The Deposit Rules

    Where the invention involves a biological material and words alone cannot sufficiently describe how to make and use the invention in a reproducible manner, access to the biological material may be necessary for the satisfaction of the statutory requirements for patentability under 35 U.S.C. 112.
  5. e Application Affected

    The sequence rules require the use of standard symbols and a standard format for sequence data in most sequence-type patent applications. They further require the submission of that data in computer readable form. Compliance is required for most disclosures of sequence data in new applications filed on or after October 1, 1990.

5 Multiple choice questions

  1. Reference to Previously Filed Identical Computer Readable Form; Continuing or Dericatiove Applications; Request for Transfer of Computer Readable Form
  2. Symbols and Format to be used for Nuclueotide and/or Amino Acid Sequence Data
  3. Notice to Comply
  4. Form Paragraphs
  5. Replacement or Supplement of Deposit
    IN A PENDING APPLICATION

5 True/False questions

  1. 2407.04Treatment of Replacement
    37 CFR 1.805(e)
    where a replacement deposit is permitted and made, the examiner will assume that the same material as described in the patent is accessible from the identified depository unless evidence to the contrary comes to the attention of the Office

          

  2. 2421.03Notification of a Failure to Comply

          

  3. 2425Requirements for Nucleotide and/or Amino Acid Sequences as Part of the Application Papers

          

  4. 2434Publishing of Patents and Patent Application Publications With Lengthy Sequence Listings

          

  5. 2411.05Content of Application with Respect to Deposited Material